Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PRO GRDO
--
George Sharp
--
a. No matter what your feelings are... he does what he says
--
b. He cleaned up the Shell, said he was, went step by step and told
all along the way
--
c. His statements all about cleaning up OTC suspect stocks and then statements about certain ones.. were met as expected by many who may
have been part of the issues. However by far over 90% of the ones he names are on suspect list by OTC and other watch dogs.
--
d. Speaking of Watch Dog.. the new Domain is coming on line and the
Yard the Watch Dog will be watching is his specialty .
--
e. George is way to smart to spend time and energy on something that will not provide ROI , anyone that has a specialty can make it into a business.
--
f. It appears that he is promoting to someone, some backer, some financial backers that he can do what his background indicates and has now developed a resume over time . Lately he is just doing what he does to show it can be done.
--
It is not overnight buidling something like GRDO.. predict in the next few months more of this will come out and follow suit into the new business model and business plan.
Level 2 taking off
--
RDGL
--
All about Company , Products , TIMING
Kayak... agree... this is based on Strategy , DD and Product
---
Daddy N... agree on that ignore , all Fake News
---
PRO RDGL.. trades again off slow, predict into start of
Feb and then News... or other will start the engine back up.
More and More info coming out
--
CNB Market by Analyst now predicted at double +
the size.
--
Will be interesting soon , already some smaller
Medical stocks being bought up where they have their
foot in the door of Medical distribution .
--
CORAL GABLES, FL / ACCESSWIRE / January 29, 2019 / With the cannabis boom just getting underway, analysts at Piper Jaffray believe we could be looking at a market value of between $250 billion to $500 billion a year. "We believe the long-term growth can be significant - both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health [and] wellness categories to CBD-infused products," said the analysts, as quoted by MarketWatch
This will go into the Hall of FAKE News
--
sub penny not a real company ..
--
Cancer cures are real
Already verified Pollack has an agreement with
the CEO of RDGL
--
nice try no glow
--
just go back to George Sharps board...
--
This is for real investors...
Bromite ... Friday and today ... were the same..
--
a. No large after hours block being sold.
--
b. Still 50% of the volume was in last hour
--
c. Low volume levels today , like the last few days
--
d. Some speculate that some noteholders will start up
again in Feb as their 'quota' was completed in Jan.
Personally IMO .. it may be some , but nothing like Jan.
--
e. Calculations are somewhat spread apart... but IMO Noteholders
(along with many commons shareholders will wait) for CEO Korenko
for any start of Month statement or Tweet etc.
--
f. Only 37 trades today .. volume a little over a million ...
--
g. I am sure many are out there , shows as of 4/2/2018 that there are
341 Shareholders... that have millions and are not trading , no worries
they know news is coming out. My big block is staying right where it
has been and continue to accumulate along the way.
--
h. IMO .. Korenko and MGT/Advisory board have M. Pollack and his company changing structure of RDGL ... plus have the capability of
getting non toxic funding to move forward.
Mr. Michael Pollack | Interim CFO
Michael Pollack, CPA is the Partner-in-Charge of KBL’s audit quality and control, and the Partner-in-Charge of KBL’s Public Company (SEC) Practices Group. He has over 20 years of experience in public accounting and consulting to both publicly traded and privately held companies. He also has vast knowledge of capital financing, debt refinancing, strategic repositioning, development restructuring, and private placement offerings.
---
He has directed various SEC engagements as well as financial service engagements as an auditor, and has been utilized as an outsourced CFO for a number of public companies all performed in accordance with the standards established by the Public Company Accounting Oversight Board. He has prepared numerous market and financial feasibility studies that have directly led to the raising of several billion of dollars in financing
===
===
===
A Professional... with a Professional Company
-
KBL , right on Fifth Street New York ...
--
http://www.kbl.com/index.php
==
KBL, LLP is a Certified Public Accounting and Business Advisory Services firm with a primary focus on meeting the needs of emerging businesses nationally and globally.
We have a multi-disciplined practice that cultivates an environment of strategic problem solvers and business innovators, always keeping you, our client, ahead of the curve.
Intimate knowledge of your business and vision enables us to deliver the most advanced solutions and strategies that will position your Company with a competitive edge. By consistently evaluating and monitoring your business objectives against the trends and conditions of the markets, we can see how best to align your vision in a landscape of constantly shifting and volatile legislative, business, and economic environments. The result of your investment in KBL as a trusted advisor ultimately positions you with the best in intellectual capital.
As accountants and advisors, we serve a diverse client base of privately and publicly held entities across the United States and the world. Working side by side with our clients, we create personalized approaches that are based on each client's unique goals, business culture, and dynamics. We then assemble the specific solutions, procedures and people necessary to assist our clients in achieving their objectives.
At KBL, our practice is focused on growing companies. Our mission is to help our clients navigate the opportunities and challenges they face to compete more effectively, enhance products and services, improve systems and procedures and, more importantly, achieve significant and sustained growth. In short, our personalized strategies support each client’s movement towards their business and financial goals.
In addition to being a peer reviewed firm, we are registered with and abide by the rules and regulations of the Public Company Accounting Oversight Board, a body created by the Sarbanes-Oxley Act to focus on overseeing the auditors of publicly held companies.
Slow T
--
I agree this is not about GS .. or postings like from IG ... all
diversionary, in fact this board should not be about either.
--
However IMO and respect your s.. George was brought in back in Aug,
Sept, to assist them on some new paths . He is a consultant on a
1099 , not an employee of RDGL. In fact , my belief is that George
has been used very little starting into 2019, as a professional Mike Pollack and his company that specialize in these efforts came in .
--
I believe (on the link) Mike Pollack was the key person that came in and the other CFO had to step aside so the proper next steps could be done. He and his NY company have ways of reaching far more finanicing and support groups than others .
--
I also believe that Ceo Dr Mike Korenko update from 2018 had Mike
Pollack and his company backing that , as it is a perfect lead in to
be talking to other companies.
--
https://www.radiogel.com/about-1/management-consultants/
Greenlink ... see twitter .. further distribution
===
Jake George CEO and Greenlink team have the
--
Quality and Regulations in place and could consult if need be
--
Decade of fine tuning the different Strains and production methods
--
Network in place
--
Packaging in place
--
already stated looking to distribute out side of WA
--
==
CE coming donw in Feb is my projection ... Financials reviewed for
both US and Canada... Twitter movement methodical and strategic, shows
Canadian side for a reason visiting.... if you look at their network
just on Twitter they are connected with ... no brainer here.
BID
-
NITE ... .018 ....38k
CSTI ... .018 .....20k
CANT ... .014..... 500k
========
========
ASK
-
CSTI .... .022 .... 20K
NITE .... .0235.... 100k
CANT .... .025 ..... 270k
ETRF ... .05 .... 25 k
==
CEO Sharp , continues to post all updates.. it takes time and
really not that much gone by .
--
However some real impatient folks selling today ... some other folks
that are getting those shares at a bargain
--
It is obvious that George has picked up on the twitter about the stocks that are at issue , anyone can double check.. they either show STOP signs on OTC or are clearly listed on other sites like OTC MARKET COMPLIANCE that
confirms all that is being indicated.
--
George is truly getting ready to take this into a business to be the WATCH DOG (Guard Dog) of the OTC regulations. His background leads right into having all the skills to do so as a CEO.
--
Stay focused Mr. Sharp on the Long Term Goal... PRO GRDO
Recommend to get on Twitter and / or website RDGL and
send messages for updates... just did also
--
Looking for more add on to this and also any Conversions info
--
Note on " ALL ANIMALS", goes with Korenko statement Human Trials
forthcoming
--
===
Richland WA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), announced that the device classification obtained from the FDA Center for Veterinary Medicine (CVM) is not limited to canine and feline sarcomas, and can be extended to a much broader population of veterinary cancers, essentially all solid tumors in animals.
A review by the international law firm, Hogan-Lovells, who are premier experts on FDA matters, confirmed the broader application of the FDA’s veterinary device classification. While the FDA does not have premarket authority over veterinary devices (i.e., products classified as a device can be brought to market without first being reviewed by the FDA) the manufacturer is responsible for assuring that the product is safe, effective, properly labeled, and otherwise in compliance with all applicable laws and regulations.
It is the company’s responsibility to maintain a strict configuration control of the product and product labeling, including applicable indications for use, to stay within the bounds of the FDA regulations. We have prepared a formal Memorandum to File to document our systematic interpretation of the regulations and our disciplined process for assuring compliance with FDA requirements.
Dr. Mike Korenko, Vivos Inc CEO stated “With this significant development we are confident that there are no regulatory obstacles to treating a wide range of tumors in animals. We intend to continue with our strategy of partnering with university veterinary hospitals to generate additional data on the safety and effectiveness of IsoPet® therapy in order to enhance the confidence of the veterinary medicine community. We will also ensure that future users obtain our certified training to administer IsoPet® according to the procedures defined in our product labeling.”
Agreed looking for CEO Jake George Update
---
I know they follow OTC Market Compliance..while not
the OTC Market group per say .. they do track the stocks
that are having issues.
--
There are many that are taking hits and getting a CE on
them.. primarily empty Shells and so forth , rightfully so .
--
Sent a note to Greenlink... with New Marketing person
coming on , need to get the CE out of the way once and for all.
--
I believe with the Financial reviews, Jake brought up .. that
is close as it has ever been to being done and also secure
their large Tax Benefit both Jake and Doug spoke on .
--
This CNB Market is starting to heat up .. the time is now
for Greenlink to use their hard work over the past year +, new
exposure on excellent Videos and get more exposure to their Twitter
site .
--
I am also sure with the Large Network Jake George has and the
respect in the Industry over the past decaded from the Peer Groups
this will show a quick return. Under the Radar.. Not for long now.
Patents
==
CEO Dr Mike Korenko holds over 22 patents himself.
--
Battelle... The leading US LABS that have the capability of
testing a multitude of items that cause issues , potential cancers
RDGL has very STRONG NETWORK PARTNERS like Battelle in this
relationship .
They are on various News Releases in a variety of items that affect
both Human and Animals . Their Labs lead the way in the US
=================
--
Battelle Laboratory is Country’s First to Obtain Additional PFAS Accreditation
Posted on Jan 16, 2019
0
SHARES
COLUMBUS, Ohio (Jan. 16, 2018)—Battelle has the first laboratory in the United States to receive National Environmental Laboratory Accreditation Program accreditation for testing of a specific suite of important chemicals.
Last November, the United States Environmental Protection Agency (EPA) updated its drinking water Method 537.1 for detecting this class of chemicals in drinking water by expanding the analyte list. The chemicals, known as PFAS—Per- and Polyfluorinated Alkyl Substances–for decades have been commonly used in firefighting foams as well as water-repellent materials, non-stick cookware and takeout containers, among many other products. Due to their possible impacts on human health, they are now emerging as an environmental contaminant of concern, particularly on and around military bases, landfills, and industrial sites.
The EPA 537.1 expansion added four PFAS analytes and Battelle’s lab in Norwell, Massachusetts is the first to receive accreditation for these additional compounds. They include GenX (hexafluoropropylene oxide dimer acid), ADONA (4,8-Dioxa-3H-perfluorononanoic acid), and two isomers of F-53B (11-chloroeicosafluoro-3-oxaundecane-1-sulfonic acid and 9-chlorohexadecafluoro-3-oxanone-1-sulfonic acid).
“This new accreditation expands our capabilities and establishes us as the leading PFAS testing lab in the country,” said Jonathan Thorn, the Battelle Norwell Laboratory Director. Battelle is also one of a limited number of laboratories than can test more challenging, non-traditional matrices for PFAS such as landfill leachate and animal tissue.
Battelle is at the forefront of site assessment and remediation for this class of chemicals that is rapidly growing in the nation’s awareness. Research is currently underway at Battelle that is urgently needed to better understand the fate and transport of PFAS compounds and how contaminated sites can best be remediated to minimize environmental and human health concerns.
About Battelle
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle makes the world better by commercializing technology, giving back to our communities, and supporting science, technology, engineering and mathematics (STEM) education. For more information, visit www.battelle.org.
NOTED Den 4 ... thanks
Agreed.. would project RDGL news out by end of Jan just
in general ... from CEO Dr Mike Korenko
--
others have posted that the latest test results should be out
shortly .
--
PRO RDGL
DjDj
--
Do your DD on the person your asking questions
to about IBGR
--
Put their IHUB name in Google.. you will get info
IBGR Group... just fyi .. noticed a lot positing on the
old Twitter site
--
new one is under APPLICATE
---
Applicate, Inc.
?
@ApplicateInc
Jan 24
More
Nexus Energy (OTC: $IBGR) Smackdown in a Battleground Stock
GRDO is clean... George went about it the right way... told all...
lived up to his statements... was transparent all the way through
---
These other Stocks... over90% of what he mentions have OTC STOP
signs on them.. they are either DARK or other issues... what is the
big deal...
---
So if folks do not believe George... and then see the STOP sign from the OTC and buy into it based on hype , when it is obvious that nothing has been going on is some case for years.. then with out any updates it jumps up .. and then someone says oh by the way , they are going current , it
is very easy to do.. the whole point in OTC land...
Do your OWN DD and then you get what you get .
TIME WILL TELL... FEB then will be a "litmus test" at start
--
interesting to see everyone's math on where the Noteholders are
currently... respect all opinions ..
--
agreed... at least it was not "666"
--
Still, trends broken today .. no last minute million
plus sale right after closing....
--
Messages coming out changing format, broader in scope..
--
January under our belt ... just about
--
Weather changing (at least West Coast) starting to see flowers
and buds on trees ready to bloom in the next Month
--
RDGL... all good
Monday should be interesting
--
Today
--
Volume down over 40%
---
Trades down over 30% avg
--
and NO end of day one million + trade right
after hours ..
--
HMMMMM
IBGR group.. Level 2 is about as thin as it will ever be..
--
can clean this right up
Last hour trend these past two weeks ... 30-50% of daily total
volume
--
lets see if that crazy trade happens again a few clicks after close...
--
Slowly but surely .... and we are trending towards News time also
--
I do not want to be any older in life.. but I would be glad to get
Jan under my belt here...
--
Pro RDGL and all the RDGL Mgt Team and Product(S)
Truth be told.. TF
--
Evolve over time.... where I have heard that before
--
Oh Yea
--
Pro RDGL
---
“If you really look closely, most overnight
successes took a long time.”
– Steve Jobs
just went in and bought a block as I have been daily adding
--
somemore out there it appears Level 2..
--
That is fine will just keep adding
--
same daily trend... here we go into the last two hours.. still well
below a million shares moved... last hour will be interesting.
--
RDGL messages continue to expand in detail, scope and structure well
beyond canine and feline ..(still focus there) ...
--
I am fine to hang on adding into the end of January and into Feb.
--
However,.. any News is GOOD NEWS...
Look at the latest on TWITTER..
---
While this could be a Poster for Greenlink Marketing
--
I also see the MAIN MESSAGE.... "Cultivating GENETICS"
--
You can expect with no DOUBT.. the Greenlink Team has
mastered the Genetics .. .and in the CNB World out there,
QUALITY is the new buzz word...
--
Quality equals Genetics for every use ... infusion, oils,
medical, you name it ... .
--
STRATEGY behind all these Twitter messages the past two months
and is directly related to the Videos put out ...
--
NICE ... So once the CE is down and folks look at the past or what
has been done and on going.... it will speak for itself...
As TF indicated.. Level 2 looking good
--
over 2 million shares bought in the past 30 minutes
--
onward and forward
Thank DPLV...
--
Easy to break it down.. when all the DD matches...
--
So we will give the credit to the RDGL Team... Good Reading
but the best by FAR.. is the Strategic Objectives for 2019.
--
That word HUMAN .. with TESTING.. keeps coming out . Get this
team ... with the ISO Thearputics Team and patents.. and get the
BATTELLE LABS involved... major players about to make something
MAJOR happen.
---
Vivos Inc 2018 Highlights
Email Print Friendly Share
January 09, 2019 07:00 ET | Source: Vivos Inc.
Richland WA, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL)
-
The Board of Directors Reports:
In spite of being handcuffed by legacy debt financing, Vivos Inc made considerable progress in 2018. This was largely possible due to the breakthrough nature of the IsoPet® technology. Major accomplishments this past year include the following:
--
• Completed planned testing at Washington State University for the treatment of feline sarcoma. Most importantly this study confirmed the effectiveness of IsoPet for killing cancer. It further allowed us to refine techniques for safe and efficient use in future animal and human therapies.
• Utilized professional society conferences to communicate the potential of our product to veterinary and medical professionals:
o For animal therapy we had strong reception to IsoPet® at the Veterinary Cancer Society Conference setting the stage for commercializing IsoPet in the veterinary community. This is a key conference that is attended by veterinarians from across the USA and internationally.
o For human therapy we had outstanding response to our poster presentation at the Society of Nuclear Medicine and Medical Imaging (SNMMI) Conference in Philadelphia. We were invited to submit a paper on new innovative technology to their technical journal and also had strong interest from the president of the China Society of Nuclear Medicine.
• Intellectual property protection is a high priority:
o We updated our trademark protection of RadioGel, which is currently registered in 17 countries.
o We renegotiated our license agreement with Battelle to obtain a significant reduction in fees.
o The U.S. Patent and Trademark Office issued the Certificate of Registration for the marks RadioGelTM and IsoPet®.
• The FDA reviewed our Label and confirmed the classification of IsoPet® as a device for animal sarcoma cancer therapy. There are no remaining regulatory obstacles to commercialize IsoPet® for those cancers.
• We strengthened the Veterinary Medicine Advisory Board by adding Tariq Shah with strong commercial expertise to work with Dr. Alice Villalobos, the internationally recognized Chair of our Board.
• We established a test plan with the University of Missouri for treatment of canine soft tissue sarcoma and administered IsoPet in the first two patients. It takes about three months to assess the safety and effectiveness of the therapy.
o The first canine’s tumor was classified as CR, Complete Response. This was unprecedented compared to the standard therapies, in which the tumors tend to reoccur.
o The latest examination of the second patient, treated in late October, also looks promising with response similar to the first canine patient.
• We retained well-known analyst and consultant, George Sharp, as an Advisor. He is widely respected as a watchdog for ethical behavior in the small cap markets and has outstanding business sense.
• We strengthened our management team by bringing on Michael Pollack as our new CFO. Michael has extensive experience guiding public companies.
• Completed common stock equity financing to halt toxic selling and eliminate the secured toxic debt. This was necessary to curb the death spiral of our share price.
• Our commercialization plan is to first pilot with a local clinic and then to partner with several regional clinics across the United States:
o Signed a Memorandum of Understanding with Vista Veterinary Hospital to become the pilot clinic for commercial IsoPet® therapy. We are currently working with them on certification training and to obtain their Radioactive Material Handling license.
o Identified several interested veterinary clinics at the VCS conference that are candidates for regional clinics.
==
==
We are looking forward to another productive year in 2019. Our strategic objectives are
• Initiate the commercial sales of IsoPet.
• Secure adequate funding to expand IsoPet therapy in key regional centers.
• Begin the pre-clinical testing for human therapy.
• File for additional patent(s) to enhance our intellectual property protection.
• Continue to reduce production costs to make IsoPet more affordable for the average pet owner.
--
We realize that our loyal shareholders have gone through many emotional peaks and valleys with respect to our share price. We believe that with the elimination of our toxic debt and our progress in the development of IsoPet™ and our pending human trial testing that these trying times are at an end. We will be taking further steps to strength our company’s position while maximizing shareholder value in the near future. The Board of Directors appreciates the patience of our shareholders as we develop a legacy of advanced treatments for cancerous tumors.
Thanks CH
--
I read it differently ... but we are agreed PRO RDGL
--
The reason IMO, to have specific Market Stand still date
range .. was that the Noteholder already had the capability
of doing it right after Oct 10.
--
In any event , X amount have been converted and the volume
restriction is on for the first six months past Jan 1.
==
The most I have seen in one day at the latest trend of selling
a few clicks after close... has been six million.. then it went
Four Million for some days.. then two million .. then one million
for one day and a strange number of 1, 588, 520 or something close
to that yesterday .
===
With that being said and using he example of lets say Twenty Trading days for sake of argument .. .if two million per day ... Then 40 million per month converted +/- ... as example only .
----
I am also of the belief that since we do not know who or what the NOTEHOLDERS are .. they are just looking at this as an investement .
If they converted their shares at even .0065 from the origina .004 they got it at ... that is still over a 35% increase. They may convert
to a certain number and hold.
--
So in this case I am still going with the rush is over at end of January and then news comes out ... Product results. look at the
DD as most of the RDGL Core group continues to do.
--
Also there is a strategy in the TWITTER postings .. they have changed where still talking about the Moose and Dog 3.. but now the majority is about different types of Cancer, Cures, Human , and so forth ... quite a change in the past month.
Dr Mike Korenko ... posted a complete update for Jan and past year .. it feels due to the changes in messages , look for more and he already said it in Quote... this application will go far beyond just canine and feline applications.
--
One thing is speculation (agreed) on where Noteholders are.
--
The other is NO speculation on this being a growth Stock with verified, clarified, qualified Mgt , quantified results on the product.
--
Also they are connnected to the Labs of Iso Theraputics and Battelle , nation reknown labs that are working on all cancers..
--
This is going to be there... History in Medical Field , we are part of that with no specultaion at all.
disagree... they sold at first day past Market non activity
--
Oct 11 and beyond..
--
Then Jan 1.. volume .. regulations...
--
they are for sure out there and have been converting
Raonall... lets get going on the Marketing
--
Raonall... time to take your past NFL action out there... plus the new Marketing Manager.. .take down the CE and let them Market Greenlink....
==
SAN FRANCISCO —
Hall-of-Fame quarterback Joe Montana, looking to hit pay dirt in the legal marijuana industry, is part of a $75 million investment in a pot operator, it was announced Thursday.
San Jose, California-based Caliva said it will use the investment to grow a company that includes a farm, a retail store, distribution center and a delivery service. It also distributes its branded products in dozens of other retail outlets in the state.
Paul is a very well respected attorney in the Tacoma Area
--
Nice
--
https://www.donionlaw.com/
Today ... a little over 4 million shares moved, Low volume folks
not selling.
--
same trend... back and forth low 6's for most of
day , very small trades for the most part... less than 100 dollar
moves 10,000 or so .
--
HOWEVER... once again a few clicks after a large block
sold.. but this was not a nice and even.. it was at 1603 ET
and amount was 1,557,880 ... or 36% of todays total
--
Strange number like it was cleaning something up
--
In any case... following trend that into FEB things will
change...
--
My estimate is the majority + of the 625 gone ... converted..
--
PRO GRDO... onward and forward...
==
Look at that time ... IG must have just got off his
shift at IHOP ... yep .. everday around noon
--
Eddo... No it is not trading
--
however on Level 2.. there is in fact one ASK..
--
CDEL....... for $20.00 ... 425 shares...
===
just caught my eye is all.
-
Onward and Forward to see how this plays out
LOL, Funny with all respect.. but will be interesting NMD , to really
see what happens ...
--
you can NOT PAY FOR THIS MUCH ENTERTAINMENT ...
--
Onward and Forward
well... you can always hit the ASK on second level for PLFMD..
--
at $20.00 now sitting on 425 shares...
--
Be the first
SOS... for Champ... Stuck on Silliness
--
Onward and Forward.
--
RDGL is all about Product, development, Medical History
in the making ...
--
There is NO .. NADA... R/S in the making... lets get through
the conversion and into FEB.... Korenko is due to send out
Monthly update.
--
As a reminder Korenko did a GREAT Job on the 2018 update at
the start of this month.... I go back and read it just to step
back and continue to say .. these FOLKS are the REAL DEAL>